PATENT CLAIM ANALYSIS

Application Number: 16112008
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "139100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 9):
The isolated antibody or antigen binding fragment according to  claim 1 , wherein the antigen-binding fragment which binds to common \u03b3 chain comprises:\n (i) a light chain variable region comprising the following CDRs: \n LC-CDR1: (SEQ ID NO: 68) RSSQSLLHSNGYNYLD   LC-CDR2: (SEQ ID NO: 69) LGSNRDS   LC-CDR3: (SEQ ID NO: 70) MQGTHWPWT; and\n (ii) a heavy chain variable region comprising the following CDRs: \n HC-CDR1: (SEQ ID NO: 48) GYYWS   HC-CDR2: (SEQ ID NO: 49) EINHSGSTNYNPSLKS   HC-CDR3: (SEQ ID NO: 77) SPGGYSGGYFQH.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 96.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15922921', '15229336', '15750425', '15908218', '15495048']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8563303671975961
- 35 USC 102 Novelty (BERT): 0.7359201549528839
- Combined Prediction Score: 0.8442893459731249
- Mean Citation Score: 841.4670800000001
- Max Citation Score: 971.493
- Similarity Product: 807.1062478809358

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test